Total planned funding: $649,641,650
Clear active filters
Ethiopia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Ethiopia | $649,641,650 |
Organizational Types
Host Country Government Agency | $125,259,493 |
University | $113,793,671 |
Private Contractor | $102,933,324 |
NGO | $98,292,992 |
Unknown | $86,901,335 |
Own Agency | $50,151,974 |
Implementing Agency | $34,290,096 |
Multi-lateral Agency | $19,525,393 |
Other USG Agency | $17,184,952 |
FBO | $1,308,420 |
Program Areas
Treatment | $237,168,416 |
Care | $137,890,540 |
Governance and Systems | $117,805,397 |
Prevention | $86,996,695 |
Management and Operations | $34,915,010 |
Testing | $33,841,676 |
Budget Codes
HTXS: Treatment: Adult Treatment | $204,909,444 |
OHSS: Health Systems Strengthening | $60,308,847 |
HKID: Care: Orphans and Vulnerable Children | $55,822,277 |
HBHC: Care: Adult Care and Support | $53,069,764 |
HVOP: Sexual Prevention: Other Sexual Prevention | $43,946,408 |
HVSI: Strategic Information | $37,366,905 |
HVMS: Management and Operations | $34,915,010 |
HVCT: Testing: HIV Testing and Counseling | $33,841,676 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $23,697,915 |
HVTB: Care: TB/HIV | $20,824,272 |
PDTX: Treatment: Pediatric Treatment | $20,284,099 |
HLAB: Laboratory Infrastructure | $20,129,645 |
HTXD: Treatment: ARV Drugs | $11,974,873 |
HMBL: Biomedical Prevention: Blood Safety | $8,229,954 |
PDCS: Care: Pediatric Care and Support | $8,174,227 |
HMIN: Biomedical Prevention: Injection Safety | $4,980,489 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $3,449,541 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $2,662,126 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $30,262 |
Top Partner Programs
Not Available:
$82,009,289
Countries/Regions
Columbia University:
$57,221,379
Countries/Regions
USG Aggregated Agencies:
$47,161,782
Countries/Regions
Chemonics International:
$35,790,696
Countries/Regions